On the other hand, previous studies suggest that altered lysine transport, potentially mediated by reduced cationic amino acid transporter-1 (CAT-1) expression, contributes to the pathophysiology of ALS (65). This evidence concerns the gene SLC7A1 and amyotrophic lateral sclerosis.